Skip to main content
Livermore
Livermore
ZHEN

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Blueprint Medicines Corp changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of BPMC: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders215222+7
Shares63.2M63.8M+686.3K (+1.1%)
Value$2.84B$4.03B+$1.19B (+41.7%)

New holders (32)

Institutions that held Blueprint Medicines Corp at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to BPMC in Q2 2023
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC1,798,300$113.7M3.00%
Polar Capital Holdings Plc500,000$31.6M0.22%
Avidity Partners Management LP415,000$26.2M0.92%
Hood River Capital Management LLC273,449$17.3M0.51%
Oracle Investment Management Inc41,377$2.62M2.47%
Adage Capital Partners GP, L.L.C.32,903$2.08M0.00%
Zimmer Partners, LP28,400$1.79M0.04%
Harbor Capital Advisors, Inc.24,353$1.54M0.31%
Allianz Asset Management GmbH14,300$903.8K0.00%
Capula Management Ltd10,280$649.7K0.08%
Aigen Investment Management, LP8,635$545.7K0.08%
Bank of Montreal6,605$418.9K0.00%
Pallas Capital Advisors LLC6,710$388.4K0.02%
Echo Street Capital Management LLC5,974$377.6K0.00%
Efg Capital International Corp.5,500$347.6K0.08%
Blair William & Co5,367$339.2K0.00%
Janney Montgomery Scott LLC4,230$267.0K0.00%
First Republic Investment Management, Inc.3,963$250.5K0.00%
Two Sigma Securities, LLC3,727$235.5K0.02%
Xponance, Inc.3,556$224.7K0.00%
Neo Ivy Capital Management3,516$222.0K0.12%
JustInvest LLC3,313$209.4K0.01%
Altfest L J & Co Inc3,243$205.0K0.03%
BIT Capital GmbH2,855$180.4K0.02%
Exchange Traded Concepts, LLC2,438$154.1K0.00%
SG Americas Securities, LLC2,179$138.0K0.00%
Headlands Technologies LLC1,422$89.9K0.03%
Lazard Asset Management LLC1,103$69.0K0.00%
Pinebridge Investments, L.P.734$46.4K0.00%
Versant Capital Management, Inc10$6320.00%
Allworth Financial LP8$5060.00%
Sofos Investments, Inc.63$3230.00%

Sold out (25)

Institutions that held Blueprint Medicines Corp at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of BPMC in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Baker Bros. Advisors LP333,665$15.0M
Man Group plc–$5.96M
Nomura Holdings Inc106,693$4.80M
Schonfeld Strategic Advisors LLC69,629$3.13M
Tekla Capital Management LLC67,710$3.05M
Squarepoint Ops LLC63,989$2.88M
Assenagon Asset Management S.A.49,847$2.24M
Two Sigma Advisers, LP47,200$2.12M
Voloridge Investment Management, LLC41,352$1.86M
Alps Advisors Inc39,523$1.78M
D. E. Shaw & Co., Inc.21,270$956.9K
Two Sigma Investments, LP12,800$575.9K
Tudor Investment Corp Et Al9,663$435.0K
Magnetar Financial LLC9,266$416.9K
Fox Run Management, L.L.C.5,300$238.4K
Twinbeech Capital LP4,849$218.2K
Wolverine Trading, LLC4,545$201.0K
PEAK6 Investments LLC4,201$189.0K
Values First Advisors, Inc.2,618$117.8K
Dark Forest Capital Management LP1,400$63.0K
Baillie Gifford & Co315$14.2K
Advisory Services Network, LLC240$10.8K
Belpointe Asset Management LLC147$6.61K
SRS Capital Advisors, Inc.7$315
Ellevest, Inc.2$90